OUR WORLD: COVID-19 PANDEMIC, AMERICAN BIG BUSINESS PHARMA ( MONOPOLY), AND POLITICS UNDER ECONOMIC GLOBALIZATION

 
"GLOBALIZATION: supposedly a 'borderless world;' it's the buzzword you can't escape. But what on earth does it mean? 

For some, it's the ticket to a democratic world of instant communication and global prosperity. While for others, it's a money-mad juggernaut, spinning wildly out of control, threatening both cultural and biological diversity. 

The complex entanglement of culture and economics has been growing since the colonial era and even before. So today commercial culture and the Western consumer model have seeped into every corner of the globe while gaps in wealth, food security, and social provision continue to grow." - WAYNE ELLWOOD, author "The No-Nonsense Guide to Globalization," 2001

NOTES TO READERS:  
1. Colored and/or underlined words are HTML links. Click on them to see the linked posts/articles. Forwarding this and other posts to relatives and friends, especially those in the homeland, is greatly appreciated. To share, use all social media tools: email, blog, Google+, Tumblr, Twitter, Facebook, etc. THANKS!!
2. Click the following underlined title/link to checkout these Essential/Primary Readings About Us Filipino Natives:
Primary Blog Posts/Readings for my fellow, Native (Malay/Indio) Filipinos-in-the-Philippines
3. Instantly translate to any of 71 foreign languages. Go to the sidebar on the right to choose your preferred language.
*************************

LET US NOT KEEP OUR HEADS IN THE SAND

To be persuasive we must be believable; to be believable we must be credible; credible we must be truthful." - Edward R. Murrow (1908-1965)

OUR AMERICA: COVID-19, BIG PHARMA, & FURTHER MAXIMIZING PROFITS VIA GOVERNMENT PUSH FOR BOOSTER SHOTS...TOP FDA ADVISORS/REGULATORS RESIGN IN PROTEST.

Our politicians are beholden to Wall Street Big Money investors. This time it's to Big Pharma.

The Biden-Harris Democratic Party White House announced that Covid-19 booster shots would start Sept. 20, ahead of approval of the idea by the FDA or discussion by the country’s Advisory Committee on Immunization Practices.

That move from the White House did not go unnoticed by FDA staff. Prominent public health officials have debated the need for boosters, prompting many administration officials to take to social media and airwaves to clarify the who/what/when of boosters. The result is a confused American public and world health officials who consider America’s encouragement of third shots (while so much of the world’s population hasn’t had the first shot) greedy and gluttonous.

On Tuesday, August 31, two top FDA vaccine regulators resigned — a decision that one former official said was rooted in anger over the agency’s lack of autonomy in the booster planning so far. A current health official said the pair, Marion Gruber and Philip Krause, leftover differences with FDA’s top vaccine official Peter Marks.

The departure of Gruber and Krause has been acknowledged inside and outside the agency as a loss for the globe, and there’s a good amount of speculation that the White House jumping in front of the FDA was the final straw. That story is certainly plausible — but it is more likely that their decisions to leave reflect a growing tension between career officials who have been pushed to the brink and felt at times irrelevant or unsupported.

Now the agency is facing a potential mutiny among its staff and outside vaccine advisers, several of whom feel cut out of key decisions and who view the plan to offer boosters to all adults as premature and unnecessary.

***

[NOTE: Remember that on June 14, 2021 - Three experts have resigned from the FDA’s advisory committee following the agency’s approval of Biogen’s Alzheimer’s drug, aducanumab, according to multiple reports.

FDA approved aducanumab at the beginning of last week. This marked the first Alzheimer’s drug approval in nearly 20 years and the first one to address the cognitive decline in patients with the illness.

In November 2020, FDA’s Peripheral and Central Nervous System Drugs Advisory Committee voted against recommending the drug.

Dig Deeper

1. Phase 3 Clinical Trial to Study Antibody for Alzheimer’s Disease

2. FDA Approves Eli Lilly’s Tau Pathology Drug For Alzheimer’s

3. Antidepressant Ineffective Against Apathy in Alzheimer’s Patients

Specifically, 10 of the 11 committee members voted that there was not enough evidence to show aducanumab could slow cognitive decline, recommending against its approval, according to STAT. The 11th member voted “uncertain.” - SOURCE: PHARMA NEWS INTELLIGENCE ] Also: Pfizer Expects $33.5 Billion In Vaccine Revenue In 2021 Vaccine Monopolies to humongous profits

The Great Vaccine Robbery - OXFAM

What We Actually Know About Waning Immunity